BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2907649)

  • 1. KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. I. Antipsychotic and anxiolytic activity in comparison with chlorpromazine, clozapine, diazepam and buspirone.
    Ruhland M; Krähling H; Fuchs A; Schön U
    Pharmacopsychiatry; 1988 Nov; 21(6):396-8. PubMed ID: 2907649
    [No Abstract]   [Full Text] [Related]  

  • 2. KC 9172 (free base of KC 7218)--an antipsychotic/anxiolytic compound. II. Discrimination from typical neuroleptics and benzodiazepine-like minor tranquilizers.
    Krähling H; Fuchs A; Ruhland M; Schön U; Mol F; Tulp M
    Pharmacopsychiatry; 1988 Nov; 21(6):399-401. PubMed ID: 2907650
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of umespirone as a potential anxiolytic and antipsychotic agent.
    Barnes NM; Costall B; Domeney AM; Gerrard PA; Kelly ME; Krähling H; Naylor RJ; Tomkins DM; Williams TJ
    Pharmacol Biochem Behav; 1991 Sep; 40(1):89-96. PubMed ID: 1685786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies into the ECG effects of tedisamil (KC 8857) in rats.
    Howard PG; Abraham S; Courtice ID; Walker MJ
    Proc West Pharmacol Soc; 1989; 32():183. PubMed ID: 2780585
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of umespirone to the sigma receptor: evidence for multiple affinity states.
    Itzhak Y; Ruhland M; Krähling H
    Neuropharmacology; 1990 Feb; 29(2):181-4. PubMed ID: 1970425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable-interval schedules of timeout from avoidance: effects of anxiolytic and antipsychotic drugs in rats.
    Galizio M; Journey JW; Royal SA; Welker JA
    Pharmacol Biochem Behav; 1990 Oct; 37(2):235-8. PubMed ID: 1981935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of AP-5-induced sniffing stereotypy links umespirone to atypical antipsychotics.
    Schmidt WJ; Krähling H; Ruhland M
    Life Sci; 1991; 48(6):499-505. PubMed ID: 1671523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists at the serotonin-3 receptor can reduce the fear-potentiated startle response in the rat: evidence for different types of anxiolytic activity?
    Nevins ME; Anthony EW
    J Pharmacol Exp Ther; 1994 Jan; 268(1):248-54. PubMed ID: 7905528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of high-affinity synaptosomal uptake of gamma-aminobutyric acid by a bicyclo-heptane derivative.
    Kovács I; Maksay G; Simonyi M
    Arzneimittelforschung; 1989 Mar; 39(3):295-7. PubMed ID: 2502985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiolytic activity of SC-48274 compared with those of buspirone and diazepam in experimental anxiety models.
    Ogawa N; Hara C; Takaki S
    Jpn J Pharmacol; 1993 Feb; 61(2):115-21. PubMed ID: 8096257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zacopride: anxiolytic profile in rodent and primate models of anxiety.
    Costall B; Domeney AM; Gerrard PA; Kelly ME; Naylor RJ
    J Pharm Pharmacol; 1988 Apr; 40(4):302-5. PubMed ID: 2900320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors.
    Helton DR; Tizzano JP; Monn JA; Schoepp DD; Kallman MJ
    J Pharmacol Exp Ther; 1998 Feb; 284(2):651-60. PubMed ID: 9454811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological screening of some N,N'-bis-[4-(4-aryl-1-piperazinyl)butyl]-substituted derivatives of 1,8-dimethylbicyclo-[2.2.2]oct-7-ene-2,3,5,6-tetracarboxydiimide.
    Turło J; Zawadowski T; Rump S; Jakowicz I; Gidyńska T; Gałecka E
    Pol J Pharmacol; 1994; 46(5):451-5. PubMed ID: 7894533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of the antiarrhythmic properties of eicosanoid inhibitors, free radical scavengers and potassium channel blockers on reperfusion induced arrhythmias in the rat.
    Beatch GN; Courtice ID; Salari H
    Proc West Pharmacol Soc; 1989; 32():285-9. PubMed ID: 2780604
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of buspirone on operant behavior of laboratory rats and cynomolgus monkeys.
    Geller I; Hartmann RJ
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):25-33. PubMed ID: 6130070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anxiolytic effect of zacopride enantiomers in diazepam-withdrawn rats.
    File SE; Andrews N
    Eur J Pharmacol; 1993 Jun; 237(1):127-30. PubMed ID: 8102974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of buspirone and diazepam on negative contrast in one-way avoidance learning.
    Torres C; Morales A; Cándido A; Maldonado A
    Eur J Pharmacol; 1995 Jul; 280(3):277-84. PubMed ID: 8566095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose human pharmacology of umespirone.
    Holland RL; Wesnes K; Dietrich B
    Eur J Clin Pharmacol; 1994; 46(5):461-8. PubMed ID: 7957544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chlordiazepoxide, buspirone and the 5-HT3 receptor antagonist, BRL 46470, on the behaviour of oestrous and dioestrous female mice when encountering male partners.
    Gao B; Cutler MG
    Neuropharmacology; 1993 Oct; 32(10):969-75. PubMed ID: 7905193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in chlorpromazine induced CNS effects when associated with other neuroleptics and anxiolytics.
    Pérez-Raya MD; Risco S; Navarro C; Jimenez J; Cabo J
    Pharm Acta Helv; 1989; 64(5-6):146-50. PubMed ID: 2569203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.